Photo by Smith Collection/Gado/Getty Images The genetics testing company 23andMe licensed the rights to a drug it developed in-house to a Spanish pharmaceutical company, Bloomberg reported. This is the first time that the company has directly sold a product it created using the genetic information collected from users. 23andMe has already shared genetic data with